Syndax Pharmaceuticals (SNDX) FCF Margin Growth (3y) (2018 - 2024)
Syndax Pharmaceuticals (SNDX) FCF Margin Growth (3y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -82,680.00 |
| Sep 30, 2024 | -29,701.00 |
| Jun 30, 2024 | 429,733.00 |
| Dec 31, 2021 | 404,193.00 |
| Sep 30, 2021 | 467,152.00 |
| Jun 30, 2021 | -234,723.00 |
| Mar 31, 2021 | -67,177.00 |
| Dec 31, 2020 | -304,351.00 |
| Sep 30, 2020 | -148,934.00 |
| Jun 30, 2020 | -177,943.00 |
| Mar 31, 2020 | -4,840.00 |
| Dec 31, 2019 | 6,587.00 |
| Sep 30, 2019 | 152,108.00 |
| Jun 30, 2019 | -100,213.00 |
| Mar 31, 2019 | -231,762.00 |
| Dec 31, 2018 | -254,401.00 |
| Sep 30, 2018 | -316,981.00 |
| Jun 30, 2018 | 1.95 Mn |